Company intelligence / Profile preview

Donaldson, Lufkin & Jenrette

New York, New York, United States

Ownership: Private
Employees: ~11300
Development stage: Other

Overview

Donaldson, Lufkin & Jenrette (DLJ) was a major U.S. investment bank, founded in 1959, known for pioneering independent institutional research on Wall Street and growing into a top-ten investment banking firm. Although not a biotech, pharma, or healthcare company itself, its investment banking division provided financial services to life science and healthcare companies, including biotech. The firm was acquired by Credit Suisse in 2000 and subsequently ceased independent operations.

Industry: Investors

Beyond the preview

Go deeper on Donaldson, Lufkin & Jenrette.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Donaldson, Lufkin & Jenrette.

Explore the full profile